James Pennington
Corporate Officer/Principal at The University of California, San Francisco
James Pennington active positions
Companies | Position | Start | End |
---|---|---|---|
The University of California, San Francisco | Corporate Officer/Principal | 01/01/1986 | - |
Career history of James Pennington
Former positions of James Pennington
Companies | Position | Start | End |
---|---|---|---|
FIRST WAVE BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 30/05/2018 | 31/03/2022 |
ANTHERA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2007 | 01/01/2010 |
CoTherix, Inc.
CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Chief Tech/Sci/R&D Officer | 01/02/2004 | 01/03/2007 |
INTERMUNE INC | Chief Tech/Sci/R&D Officer | 01/01/2004 | 01/01/2004 |
Alpha Therapeutic Corp.
Alpha Therapeutic Corp. BiotechnologyHealth Technology Part of Grifols SA/Grifols Family/, Alpha Therapeutic Corp. develops plasma derived products. The company is based in Los Angeles, CA. | Chief Tech/Sci/R&D Officer | 01/01/2001 | 01/01/2001 |
Shaman Pharmaceuticals, Inc.
Shaman Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shaman Pharmaceuticals, Inc. engages in the discovery, development, and marketing of novel, proprietary botanical dietary supplements from tropical plant sources. The company was founded by Lisa A. Conte in May 1989 and is headquartered in San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01/10/1997 | 01/02/1999 |
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Chief Tech/Sci/R&D Officer | 01/09/1986 | 01/10/1997 |
Harvard Medical School | Corporate Officer/Principal | - | - |
░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
Training of James Pennington
University of Oregon | Undergraduate Degree |
Oregon Health & Science University | Doctorate Degree |
Statistics
International
United States | 13 |
Operational
Chief Tech/Sci/R&D Officer | 8 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 9 |
Consumer Services | 5 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
ANTHERA PHARMACEUTICALS, INC. | Health Technology |
FIRST WAVE BIOPHARMA, INC. | Health Technology |
Private companies | 6 |
---|---|
CoTherix, Inc.
CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Health Technology |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | Health Technology |
Shaman Pharmaceuticals, Inc.
Shaman Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shaman Pharmaceuticals, Inc. engages in the discovery, development, and marketing of novel, proprietary botanical dietary supplements from tropical plant sources. The company was founded by Lisa A. Conte in May 1989 and is headquartered in San Francisco, CA. | Health Technology |
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Health Technology |
InterMune, Inc.
InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Alpha Therapeutic Corp.
Alpha Therapeutic Corp. BiotechnologyHealth Technology Part of Grifols SA/Grifols Family/, Alpha Therapeutic Corp. develops plasma derived products. The company is based in Los Angeles, CA. | Health Technology |
- Stock Market
- Insiders
- James Pennington
- Experience